Drug History: TAGAMET HB

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	TAGAMET HB
FDA Application No:	(NDA) 020238
Active Ingredient(s):	CIMETIDINE
Company:	GLAXOSMITHKLINE

Label History

View the label approved on May 17, 2005 for TAGAMET HB, (NDA) 020238

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
10/4/2006	015	Manufacturing Change or Addition	Letter
5/10/2005	013	Labeling Revision	Letter Label
8/11/1999	012	Control Supplement
5/14/1999	011	Package Change
11/6/1998	010	Control Supplement
12/10/1998	009	Package Change
3/5/1998	007	Package Change
6/5/1998	006	New Dosage Regimen
4/15/1997	005	Control Supplement
11/15/1995	004	New or Modified Indication
3/29/1996	003	Labeling Revision
7/23/1996	002	Manufacturing Change or Addition
8/21/1996	001	Formulation Revision
6/19/1995	000	Approval

Therapeutic Equivalents